Dergi makalesi Açık Erişim

A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer

Demirkol, Secil; Gomceli, Ismail; Isbilen, Murat; Dayanc, Baris Emre; Tez, Mesut; Bostanci, Erdal Birol; Turhan, Nesrin; Akoglu, Musa; Ozyerli, Ezgi; Durdu, Sevi; Konu, Ozlen; Nissan, Aviram; Gonen, Mithat; Gure, Ali Osmay


DataCite XML

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/44607</identifier>
  <creators>
    <creator>
      <creatorName>Demirkol, Secil</creatorName>
      <givenName>Secil</givenName>
      <familyName>Demirkol</familyName>
      <affiliation>Bilkent Univ, Dept Mol Biol &amp; Genet, Ankara, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Gomceli, Ismail</creatorName>
      <givenName>Ismail</givenName>
      <familyName>Gomceli</familyName>
      <affiliation>Antalya Educ &amp; Res Hosp, Dept Surg Gastroenterol, Antalya, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Isbilen, Murat</creatorName>
      <givenName>Murat</givenName>
      <familyName>Isbilen</familyName>
      <affiliation>Bilkent Univ, Dept Mol Biol &amp; Genet, Ankara, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Dayanc, Baris Emre</creatorName>
      <givenName>Baris Emre</givenName>
      <familyName>Dayanc</familyName>
      <affiliation>Izmir Univ Econ, Fac Med, Izmir, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Tez, Mesut</creatorName>
      <givenName>Mesut</givenName>
      <familyName>Tez</familyName>
      <affiliation>Ankara Numune Training &amp; Res Hosp, Dept Surg 5, Ankara, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Bostanci, Erdal Birol</creatorName>
      <givenName>Erdal Birol</givenName>
      <familyName>Bostanci</familyName>
      <affiliation>Yuksek Ihtisas Training &amp; Res Hosp, Dept Gastroenterol Surg, Ankara, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Turhan, Nesrin</creatorName>
      <givenName>Nesrin</givenName>
      <familyName>Turhan</familyName>
      <affiliation>Chaim Sheba Med Ctr, Dept Gen &amp; Oncol Surg Surg C, Tel Hashomer, Israel</affiliation>
    </creator>
    <creator>
      <creatorName>Akoglu, Musa</creatorName>
      <givenName>Musa</givenName>
      <familyName>Akoglu</familyName>
      <affiliation>Yuksek Ihtisas Training &amp; Res Hosp, Dept Gastroenterol Surg, Ankara, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Ozyerli, Ezgi</creatorName>
      <givenName>Ezgi</givenName>
      <familyName>Ozyerli</familyName>
      <affiliation>Bilkent Univ, Dept Mol Biol &amp; Genet, Ankara, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Durdu, Sevi</creatorName>
      <givenName>Sevi</givenName>
      <familyName>Durdu</familyName>
      <affiliation>Bilkent Univ, Dept Mol Biol &amp; Genet, Ankara, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Konu, Ozlen</creatorName>
      <givenName>Ozlen</givenName>
      <familyName>Konu</familyName>
      <affiliation>Bilkent Univ, Dept Mol Biol &amp; Genet, Ankara, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Nissan, Aviram</creatorName>
      <givenName>Aviram</givenName>
      <familyName>Nissan</familyName>
      <affiliation>Chaim Sheba Med Ctr, Dept Gen &amp; Oncol Surg Surg C, Tel Hashomer, Israel</affiliation>
    </creator>
    <creator>
      <creatorName>Gonen, Mithat</creatorName>
      <givenName>Mithat</givenName>
      <familyName>Gonen</familyName>
      <affiliation>Mem Sloan Kettering Canc Ctr, Dept Epidemiol &amp; Biostat, New York, NY 10021 USA</affiliation>
    </creator>
    <creator>
      <creatorName>Gure, Ali Osmay</creatorName>
      <givenName>Ali Osmay</givenName>
      <familyName>Gure</familyName>
      <affiliation>Bilkent Univ, Dept Mol Biol &amp; Genet, Ankara, Turkey</affiliation>
    </creator>
  </creators>
  <titles>
    <title>A Combined Ulbp2 And Sema5A Expression Signature As A Prognostic And Predictive Biomarker For Colon Cancer</title>
  </titles>
  <publisher>Aperta</publisher>
  <publicationYear>2017</publicationYear>
  <dates>
    <date dateType="Issued">2017-01-01</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/44607</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.7150/jca.17872</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">Background: Prognostic biomarkers for cancer have the power to change the course of disease if they add value beyond known prognostic factors, if they can help shape treatment protocols, and if they are reliable. The aim of this study was to identify such biomarkers for colon cancer and to understand the molecular mechanisms leading to prognostic stratifications based on these biomarkers.</description>
  </descriptions>
</resource>
39
11
görüntülenme
indirilme
Görüntülenme 39
İndirme 11
Veri hacmi 3.5 kB
Tekil görüntülenme 38
Tekil indirme 10

Alıntı yap